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Abstract
The developing vertebrate nervous system contains a remarkable array of neural cells organized into complex,
evolutionarily conserved structures. The labeling of living cells in these structures is key for the understanding of brain
development and function, yet the generation of stable lines expressing reporter genes in specific spatio-temporal patterns
remains a limiting step. In this study we present a fast and reliable pipeline to efficiently generate a set of stable lines
expressing a reporter gene in multiple neuronal structures in the developing nervous system in medaka. The pipeline
combines both the accurate computational genome-wide prediction of neuronal specific cis-regulatory modules (CRMs) and
a newly developed experimental setup to rapidly obtain transgenic lines in a cost-effective and highly reproducible manner.
95% of the CRMs tested in our experimental setup show enhancer activity in various and numerous neuronal structures
belonging to all major brain subdivisions. This pipeline represents a significant step towards the dissection of embryonic
neuronal development in vertebrates.
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Introduction
Recent years are witnessing a flood of new discoveries in
neuroscience largely resulting from the ability to monitor living
cells in the context of the developing nervous system using reporter
gene expression [1]. Exciting development in engineering new
proteins has extended current barriers to allow monitoring and
manipulating the activity of specific pathways within living cells
[2]–[5]. Nonetheless, these techniques rely heavily on the ability to
drive gene expression to specific developmental stages, brain
structures and cell types in a stable and reproducible way. While
great efforts have been made to efficiently obtain such stable lines,
this step remains a serious bottleneck.
In vertebrates, the most widely used strategy to express reporters
in anatomical structures relies on the use of regulatory elements,
often promoters of genes known to be expressed in the desired
structures (promoter bashing). This trial and error process is slow
and tedious. Thus, to maximize the chances of getting the right
regulatory sequences, entire loci around selected genes employing
BAC technology have been used [6]. However, this methodology
is time-consuming and the level of reporter expression may not be
high enough for proper monitoring. Other attempts to generate
reporter gene expression in various structures are based on the
random insertion of a reporter cassette into the genome [7]–[11].
Only upon activation by nearby regulatory element(s), the
transgene is expressed (enhancer trap). In mouse [12] and
zebrafish [13],[14], enhancer assays have been developed
essentially to test genomic elements for enhancer activity.
Despite advantages of one approach over the other, all these
methodologies have the significant drawback of lacking specificity.
Testing semi-random elements in vertebrates either by promoter
bashing or enhancer traps results in high screening efforts, while
BAC technology, which addresses the specificity issue by using the
entire locus instead, is experimentally tedious and cannot be scaled
up easily.
In parallel, progress has been made towards the computational
identification of regulatory regions in sequenced genomes.
Previous work has shown that, without experimental priors,
functional constraints acting on non-coding sequences are one of
the most predictive information to locate regulatory elements
[15],[16]. Thus cross-species comparison has been extensively
used to improve the detection of functional non-coding DNA
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regulatory regions using inter-species conservation was greatly
stimulated by the recent availability of various vertebrate genomes,
from mammals to fish [18]–[21] as well as the development of
more specific and sensitive alignment programs [22]–[25].
Furthermore, it has been shown that the tendency of transcription
factor binding sites (TFBS) to cluster together can be used to
predict putative CRMs [26]. This led to the development of new
methods to locate clusters of binding sites in conserved regions
[27]. An algorithm that combines both, inter-species binding site
conservation and clustering has recently been applied to the
human genome [28] resulting in the identification of 118,000
predicted human regulatory elements [29].
Here, we report the development of a new pipeline aimed at
specifically labeling, in a stable manner, various neuronal
structures in developing Oryzias latipes (medaka) embryos. This
pipeline represents two major breakthroughs compared to
previous methodologies: A selective step to predict neuronal
specific regulatory regions, combined with a new reliable enhancer
assay in medaka to efficiently obtain stable lines expressing the
reporter gene in neuronal structures (Figure 1).
The selective step applies a modified version of the computa-
tional pipeline previously described [28] to select a large number
of short (,100–1000 bp) regions predicted to be CRMs in fish. As
we predict vertebrate conservation to be an important criteria for
selecting CRMs active in neuronal structure, we filtered those
regions conserved until human and tested them in our new
enhancer assay in the medaka fish. As expected, a vast majority of
the regions resulted in a strong, reproducible expression of the
reporter gene in various neuronal structures. All the major
subdivisions of the medaka CNS were covered by at least one
expression pattern. In most of the cases, the reporter gene
expression persists beyond hatching and in all cases analyzed, at
least two independent stable lines were generated. We also show
that the enhancer activity is reminiscent of the endogenous target
gene expression, which facilitates the additional selection of
regions to target specific anatomical areas. Both, the computa-
tional prediction of CRMs and the experimental results have been
integrated into databases for easy access and queries.
Taken together, our pipeline is an important tool for labeling
neuronal structures and deciphering the regulatory grammar
controlling the development of the neuronal system in vertebrates.
Furthermore our results indicate that pan-vertebrate conserved
non-coding elements compared to less deeply conserved elements,
show activity preferentially in neuronal structures.
Results
Identification of a set of neuronal regulatory elements
One of the key steps to establish a robust pipeline for the
labeling of developmental structures is the accurate prediction of
autonomous regulatory elements in the genome. Thus, to define
genomic regions most likely involved in gene regulation, we use a
variant of the PreMod algorithm [28] applied to the medaka
genome (see Methods). The algorithm first identifies individual
TFBS based on a set of 402 high quality position-weight matrices
(PWMs), from manually curated databases of known TFBS
(Transfac [30], Jaspar [31]) and results from ChIP data [32]
(Figure 1 and methods). Next, it assesses conservation of the
predicted TFBS by comparing the medaka sequence to the
orthologous sequences in Tetraodon nigroviridis (tetraodon), Takifugu
rubripes (pufferfish) and Gasterosteus aculeatus (stickleback). Finally,
clusters of conserved homotypic or oligotypic binding sites were
identified and predicted as CRMs (Figure 1).
The algorithm resulted in the identification of 23,011 predicted
CRMs (average length 244 bp; median length 136 bp) which
contain on average 62 putative TFBSs. These regions, despite
being broadly distributed over the genome, are found significantly
more often in intergenic regions (72.4%, p-value ,0.01, Figure
S1A) and preferentially within 100 kilobases (kb) distance to the
nearest transcription start site (TSS) (93.11%, p-value ,0.01,
Figure S1B).
It has previously been shown that vertebrate conserved non-
coding elements are functional enhancers [12]. These elements are
also known to be preferentially located around developmental
genes and are consequently hypothesized to be active during
development [16]. Thus, we selected those predicted CRMs for
which a statistically significant alignment in a conserved syntenic
block with human was found (see Methods for details). Of the
resulting 491 vertebrate conserved CRMs, 69.36% lie in intergenic
regions (p-value ,0.01, Figure S1A) and 97.98% are located less
than 100 kb away from the nearest TSS (p-value ,0.01, Figure
S1B). These trends are accentuated compared to the ones
observed for the entire set of predicted CRMs.
Both sets of predicted CRMs (all CRMs and vertebrate
conserved CRMs) are stored in the PreMod database [29]
(http://premod.mcb.mcgill.ca) and listed in Supplementary
Tables S1 and S2. PreMod provides the location, score, and
binding site content of each predicted CRM. It also reports which
transcription factor matrices were used to build the CRM (tag
matrices). Predicted CRMs and surrounding genes are displayed
in their genomic context. Where in-situ expression of medaka genes
or CRM activity information is available, PreMod links to the
corresponding experimental data stored in the 4DXpress database
[33] (http://4dx.embl.de/4DXembl/reg/all/searchbyspecies/
line.do?speciesID=4).
Next, we took advantage of the large compendium of Danio rerio
(zebrafish) in-situ annotations from ZFIN [34] to shed light on the
putative function of the predicted CRMs. We first mapped the
in-situ annotation of the zebrafish genes onto their orthologs in
medaka (Methods and Figure 2A). For each of those predicted
CRMs in the medaka genome, we located the closest of the two
flanking genes and assigned its projected ZFIN annotation to the
CRM. We then tested if vertebrate conserved CRMs show a
statistically significant increase in annotations for certain develop-
mental tissues compared to the rest of predicted CRMs.
Interestingly, we found that vertebrate conserved CRMs are
associated with an elevated ratio of genes expressed in various
brain regions compared to all predicted CRMs (Figure 2B;
Tables S3 and S4). More specifically, 74% of vertebrate
conserved CRMs are associated with genes annotated as being
expressed in the central nervous system (brain: p-value =5e
24,
spinal cord: p-value =2e
23). On the other hand, enrichment is
not observed in non-neuronal tissues (pronephros: p-value =0.22,
somite: p-value =0.45, cardiovascular system: p-value =0.67).
This finding, empirically observed in mouse enhancer analysis
[12] and confirmed in this study, has important implications for
the understanding of neuronal system evolution in vertebrates.
Vertebrate conservation can be used as criteria to prioritize which
regulatory elements to use for the labeling of neuronal structures.
Development of a new enhancer assay in medaka
We developed a new enhancer assay to rapidly test genomic
regions for enhancer activity and to derive stable transgenic lines.
Aiming to set up a pipeline for large-scale analysis, we particularly
focused on generating a quick and reliable readout, which
required live monitoring of the expression pattern directly in
injected embryos. The ability to record GFP expression in a live
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system compared to the mouse embryo. Thus, we expect an
increased sensitivity in the detection of expression patterns and
better characterization of these expression patterns over time.
We use meganuclease mediated transgenesis [35] as the
method of choice to obtain highly efficient integration of the
transgene into the genome and high rates of germline
transmission. Predicted CRMs are cloned into a pBlueScript-
based transgenesis vector containing two recognition sites for the
meganuclease ISce-I [36] flanking a core promoter, a reporter
gene and a SV40-polyadenylation signal. Injected embryos were
visually monitored daily for a week to follow the spatio-temporal
pattern of GFP expression during embryonic developmental
stages (Figure 1).
Figure 1. Schema of the pipeline. (a) and (b) correspond to the computational prediction of CRMs. A subset of these CRMs is then experimentally
tested in-vivo (c) and the results of the computational prediction and experimental analysis are stored in two databases, PreMod and 4DXPress,
respectively. To evaluate the pipeline, additional experiments were performed (location analysis, analysis of the flanking gene expression patterns for
-1- the experimentally validated CRMs (by whole mount in-situ hybridization) and -2- all predicted CRMs (using ZFIN annotations)).
doi:10.1371/journal.pone.0019747.g001
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distinguish between the absence of enhancer activity and the
failure of the injection experiment. For this, we use the hsp70 core
promoter that conveniently triggers a strong and specific lens
expression from stage 28 onward [37]. The heat-inducible
zebrafish hsp70 gene is expressed during normal lens development
under non-stress conditions. This feature remains when CRMs are
cloned upstream of the core promoter, resulting in embryos with
composite expression in the lens and other domain(s) (if any)
specific for the CRM. As the correlation between lens expression
and expression in other domains is very high when testing positive
CRMs, the monitoring of lens expression itself is a very good
indicator for the injection success rate.
We therefore monitor the number of lens-positive embryos
(injection success rate) and the number of embryos showing
reproducible GFP expression in other domains (Table S5). The
percentage of successfully injected embryos showing reproducible
expression outside the lens is calculated and should be above 50%
in order to call a genomic region positive for enhancer activity. To
be significant, a consistent pattern should be seen for at least 10
individual fish. This typically requires injecting less than a hundred
embryos, which is easily achievable in a single injection
experiment. About 1 in every 50 successfully injected embryos
shows non-consistent expression most likely resulting from the
activity of local enhancers (enhancer trap). Following our defined
criteria, the enhancer trap expression pattern does not pass the
quality control and is therefore discarded. This quality control
measurement is a significant improvement over previously
described enhancer assays from which the distinction between
injection failure and lack of enhancer activity cannot be made.
In a typical experiment we obtain an injection success rate
around 46%, and, in the case of a functional enhancer, on average
66% of successfully injected embryos show a consistent expression
pattern (Table S5). These highly reproducible patterns are a good
indication that the expression patterns we observe are solely the
result of the tested enhancer activity.
A vast majority of the computationally predicted regions
shows enhancer activity
The top 10 computationally predicted vertebrate CRMs located
in eight genomic loci were experimentally tested for enhancer
activity and the injected fish were raised to generate stable
Figure 2. Analysis of the genomic location of CRMs. A. Schema of the procedure. For each predicted CRM, the closest medaka gene is
identified. Next we transferred zebrafish in-situ annotation to the medaka orthologous gene. We calculated the significance of the overrepresentation
of CRMs showing annotations for specific tissues from the vertebrate conserved dataset compared to a background set (composed of the whole set
of predicted CRMs). B. Enrichment of vertebrate conserved CRMs around genes expressed in neuronal tissues. Red squares correspond to neuronal
structures. P-values are shown with a color code, the most significant enrichments correspond to the p-values in green, the least significant to
p-values in black. Significant p-value cutoff has been determined for a 5% false discovery rate (Benjamini, Hochberg method, see Supplementary
Table S4 for numerical values).
doi:10.1371/journal.pone.0019747.g002
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of the pipeline, an additional 10 predicted CRMs evenly
distributed among the 200 top scoring candidates were tested for
enhancer activity (Table S6b).
To ensure the inclusion of all the necessary regulatory features,
we fused close-by predicted CRMs (see Methods) and extended
the predicted regions to include 200 bp flanking sequence on each
side. The resulting regions are ranging from around 500 bp to
2 kb and their location varies from 2095 bp to 63755 bp distance
to the TSS of the nearest gene (20 kb on average).
Out of the 20 tested regions, 19 triggered a reproducible
expression pattern in transient transgenic fish (Figure 3, Figures
S2, S3, S4, S5, S6, S7, S8, S9). Extrapolated to the full dataset of
the 200 top scoring regions, we estimate that 95% of the
computationally predicted CRMs have enhancer activity during
embryonic development. The fraction of validated enhancers is
higher than for another large-scale study done in mouse, which
reveals that 40% of ultra-conserved elements show enhancer
activity [12]. This result is further discussed but may be caused by
both, the prediction method involving vertebrate conserved
regions and the monitoring of reporter gene expression throughout
the whole embryonic development.
Stable transgenic lines were generated for all the top nine
candidate regions with validated enhancer activity. The same
spatio-temporal structures were labeled in transient injected fish
compared to stable lines showing that the accurate description of
enhancer activity can be done directly in the injected fish. Thus,
the required experimental time can be cut down from eight weeks
(generation time of medaka) to less than a week (time for
embryogenesis in medaka).
Stable expression of the reporter gene in neuronal
structures
Further confirming the computational predictions, all the
positive elements drive reporter gene expression in various
neuronal structures. Some patterns are limited to very specific
areas of the brain or the peripheral nervous system, sometimes,
with just a few cells being labeled. This specific expression re-
mains in stable lines suggesting that the reporter gene expression
is activated in only one or a few cell types. For example,
MEDMOD021885 highlights a cluster of a few dozen neurons
located bilaterally in the diencephalon (Figure 3d). Other CRMs
gave broader expression patterns, covering entire domain(s) of
the brain.
Figure 3. Summary of the expression patterns in stable lines. (a–i) In-situ hybridization of the flanking gene (left) and stable lines expressing
GFP under the control of the corresponding CRM (right). MEDMOD046561 did not show detectable enhancer activity. For more details on the
expression patterns of the transgenic lines, see Supplementary Figures 5–9. All embryos are shown in a dorsal view unless stated otherwise.
(a) MEDMOD021953, (b) MEDMOD021885 (frontal view), (c) MEDMOD062537, (d) MEDMOD062451, (e) MEDMOD074008, (f) MEDMOD070042,
(g) MEDMOD046007, (h) MEDMOD045693, (i) MEDMOD086628.
doi:10.1371/journal.pone.0019747.g003
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coverage of brain structures would be desired. We found that all
major subdivisions of the vertebrate CNS include labeled cells
in our assay. Reporter gene expression is found in telence-
phalic domains (line MEDMOD021953), the diencephalon (lines
MEDMOD021953, MEDMOD021885, MEDMOD046007), the
mesencephalon (lines MEDMOD074008, MEDMOD021953),
the rhombencephalon (lines MEDMOD021953 and MED-
MOD070042, among others), and the spinal cord (line MED-
MOD070042). Other neuron-containing structures, such as the
nasal epithelium were also labeled (lines MEDMOD21953 and
MEDMOD074008) (Figure 3; Figure S2).
The expression patterns of the lines have been annotated using
a controlled vocabulary from the medaka anatomical ontology
[38] and incorporated into 4DXpress. From the 32 defined
neuronal structures in the ontology, 20 (62%) were labeled in at
least one of the stable lines generated. These stable lines expressing
a reporter gene in specific cell types are an important starting point
for further functional analysis of defined brain structures. In the
long run, they offer a valuable resource for the accurate
characterization of neuronal cell types and the anatomical
description of embryonic neural structures in vertebrates.
Next, we investigated whether the reporter gene expression
monitored in our stable lines reflects the expression pattern of the
genes surrounding the CRMs in their native genomic location. For
this we performed whole-mount in-situ hybridization of the genes
flanking the CRMs and compared the resulting expression
patterns with the activity of the enhancers (Figure 1). For each
of the nine predicted CRMs showing enhancer activity, we found
that at least one of the flanking genes is expressed during
development (Figure 3). Furthermore, at least one spatio-
temporal domain of expression is common with the reporter gene
expression under the control of the corresponding enhancer.
These results strongly suggest that our enhancer assay outputs
represent an accurate description of the activity of the enhancers
in their native endogenous state.
The algorithm defines a list of transcription factors predicted to
bind to the predicted CRMs. To evaluate how pertinent this
information is, we selected three experimentally confirmed CRMs
whose activity is restricted to a very defined neuronal structure
(forebrain, diencephalon or rhombomeres). Using the ZFIN
database, we compared the expression pattern of the factors
predicted to bind these CRMs to the observed enhancer activity
and searched the literature for those transcription factors being
expressed in overlapping domains (Table S7).
For the CRM active in the rhombomeres (MEDMOD086628)
we found, among others, following transcription factors: MafB
(Val), known to be required for hindbrain segmentation and
rhombomere formation [39], Elf1 that belongs to the ephrin
family which is involved in rhombomere boundary specification in
zebrafish [40] and Evi1 that has been shown to be expressed in
rhombomeres. Interestingly, Evi1 is a target gene of the MafB
repressed transcription factor gene, hoxb1a [41],[42]. These three
transcription factors (MafB, Elf1 and Evi1) have all been predicted
to bind the MEDMOD086628 CRM, but expression domains of
Elf1 and Evi1 are not limited to the rhombomeres. Only MafB is
preferentially expressed in the rhomobomeres suggesting that
MafB restricts the CRM activity to this structure.
For the CRM active in the diencephalon (MEDMOD045693),
four transcription factors are predicted to bind this CRM (Pou3f2,
Hnf6, dl and Fos) and show overlapping and specific expression
patterns. Pou3f2, for example, is required for oxytocin neuronal
development in the hypothalamus [43]. All these factors are
expressed in additional domains suggesting that the coordinated
action of these factors in the telencephalic domain is required for
the CRM activity. The same holds true for the forebrain CRM
(MEDMOD062537).
Taken together, these results show that the factors predicted to
bind these CRMs can be used as starting points to prioritize
further experiments.
Discussion
We describe a new hybrid methodology aimed at identifying
neuronal regulatory elements in fish. With 95% success rate after
experimental validation and a 100% success rate in transgenesis,
this pipeline is, to date, the most efficient procedure to obtain
stable transgenic lines expressing reporter genes in various
neuronal structures. Furthermore, the orthologs of three of the
20 CRMs analyzed in our study have previously been tested in
mouse [12]. For one of the sequences assayed (homologous to
MEDMOD021953), expression of the reporter gene localized to
the hindbrain of mouse at stage E11.5. In comparison,
MEDMOD021953 also shows expression in the medaka hind-
brain but is not restricted to this structure. No expression was
observed for the other mouse sequence assayed by Pennacchio
et al. [12] (homologous to MEDMOD086628) while it drives
reporter gene expression in the rhombomeres in our study. These
results indicate the high sensitivity of the enhancer assay in
medaka.
We have also shown that the patterns of reporter gene
expression in our lines are reminiscent of the expression of genes
neighboring the tested CRMs. Using gene expression information
such as in-situ data, it will therefore be possible to further target the
pipeline to select regions most likely active in specific neuronal
structures. This task is facilitated by the fact that the computa-
tional predictions stored in PreMod are linked to expression data
stored in 4DXpress. Furthermore PreMod provides CRMs in their
genomic context as well as a score for each predicted regulatory
region. As a result, prior to in-vivo testing, CRMs can be targeted
based on their genomic context and score.
Finally, we have shown that the predicted CRMs conserved
across vertebrates are enriched around genes known to be
expressed in neuronal tissues. Such enrichment cannot be detected
for non-neuronal tissues (with the notable exception of pectoral fin
and pectoral fin bud) suggesting that this trend is essentially
neuronal specific. This analysis, (supported by the experimental
results) indicates that pan-vertebrate conserved CRMs have
preferred activity in neuronal structures. Our results are in
accordance with a recent finding reporting that a large population
of heart enhancers is poorly conserved [44] and suggests that the
evolutionary conservation of enhancers can vary depending on
tissue type. Conservation may reflect the ‘ancestrality’ of neuronal
structures but could also reflect the tendency of alignment
algorithms to perform better when co-linearity is preserved.
Future analysis of such conservation will shed light on evolutionary
events that lead to morphological innovation via the emergence of
new regulatory interactions.
Our pipeline, designed to create neuronal tissue specific
markers, is of great interest for analyzing enhancer activity,
identifying genetic markers and finally as a cost effective enhancer
screening tool.
Methods
CRM prediction
We collected a comprehensive set of 402 non-redundant PWMs
based on Transfac (version 9.2) [30], Jaspar core vertebrate
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with Trawler [32]. Transfac matrices were filtered based on the
following rules:
(i) All non-vertebrate transfac matrices were removed, except
for 8 drosophila matrices for factors known to be involved in
vertebrate development;
(ii) Matrices linked to more than two different TFs (from the
same species) were discarded;
(iii) Among different matrices for the same TF, only that with
the highest quality value was kept or, if not available, the
predicted sites that are the most conserved through
vertebrate evolution were used (M. Blanchette, unpub-
lished).
For each TF, binding sites were predicted in the complete non-
coding and non-repetitive regions of euteleostei (based on Ensembl
database version 41 [45] of medaka (Oryzias latipes, assembly
HdrR, Oct 2005 [46]), tetraodon (Tetraodon nigroviridis, assembly,
Tetraodon 7, Apr 2003 [47]), stickelback (Gasterosteus aculeatus,
assembly Broad S1, Feb 2006, Broad Institute) and takifugu
(Takifugu rubripes, assembly 1.0, Aug 2002 [21]) genomes). We
followed the procedure described in [28], with the following
modifications:
(i) The local GC-content background model used in [28] was
replaced by a uniform background model;
(ii) Interspecies binding site conservation was measured using a
more fexible approach that allows for (but penalizes) sites that
are slightly misaligned, up to 20 bp. In addition, conservation
was weighted as follows: hitScorealn(m, p)= hitScoremeda-
ka+max(hitScoreTetraodon, hitScoreStickleback, hitScore-
Fugu). hitScore will then depend on both the score of the
binding site in medaka and its conservation in at least one
other teleost. Note that a binding site can have a high score
without being conserved if the medaka scoring hit is strong
enough. CRMs are predicted genome-wide and are not
targeted to specific regions (regions with known develop-
mental genes for example).
A subset of 491 CRM predictions was selected using criterion
combining high CRM score and conservation with human
(vertebrate conserved CRMs). Specifically, predicted CRMs with
a BLASTZ [23] score over 2600 between medaka and human and
with a percentage identity over 60% were ordered in descending
order of CRM scores. BLASTZ homology searches in human
were restricted to the orthologous neighborhood of each CRM,
defined as following: Each medaka CRM was first associated to
the closest medaka gene having a human ortholog H, and the
human genes flanking H on the left and the right were identified.
From the list of vertebrate conserved CRMs, we selected two
datasets: [1] The top 10 scoring CRMs and [2] 10 CRMs
distributed at regular intervals in the top 200 scoring CRMs
(CRM at position 20, 40, 60, 81, 100, 120, 140, 159, 180, 200) for
experimental validation.
Gene expression analysis
Each predicted CRM is associated with the closest gene
independently of the genomic distance between them. We took
advantage of the large collection of genes with zebrafish in-situ
annotations available from the ZFIN in-situ database [34]. Next,
we transferred zebrafish in-situ annotation to the medaka
orthologs using the BioMart utility [45],[48]. If more than one
ortholog was found for a given zebrafish gene, the orthologous
gene with the highest identity was used. For each tissue (and its
subparts) and stage, we retrieved all expressed genes. The
expression annotation of each gene was subsequently transferred
to the associated CRMs (Table S3). Only tissues associated with
at least 20 vertebrate conserved CRMs are retained for further
analysis. We then calculated the significance of the overrepre-
sentation of CRMs showing annotation for specific tissues
comparing the vertebrate conserved dataset to a background set
(composed of the whole set of predicted CRMs, except vertebrate
conserved). The significance of this overrepresentation was
calculated with a one-sided fisher test. All tissue and stage
annotations follow the OBO ontology.
CRM genomic location analysis
For each CRM, the distance to the nearest annotated TSS (as
defined in Ensembl version 61) is retrieved and categorized into
distances of less than 1 kb, 1 to 10 kb, 10 to 100 kb or more than
100 kb. We also assessed if the CRMs are localized in annotated
genes or in intergenic regions (,100 or .100 kb away from the
nearest gene as defined in Ensembl version 61). One hundred
randomizations consisting of the same number of random
locations (with the same size distribution) in the medaka genome
as the number of CRMs in the real dataset has been produced.
The same location analysis was then performed on these random
datasets and the significance was calculated from these random-
izations.
Molecular cloning
The identified CRMs were PCR amplified (using LA-Taq
polymerase, Takara Bio Inc.) from genomic medaka DNA and
flanking HindIII restriction sites introduced (for primer sequences
see Table S8). After restriction digest the fragments were cloned
into a pBlueScript-based transgenesis vector containing two
recognition sites for the meganuclease ISce-I [35] flanking a
multiple cloning site followed by the core promoter hsp70::GFP
[37] and an SV40 polyadenylation signal (clone available upon
request). All constructs were verified by sequencing.
Medaka injection and screening
Injections were done as described [49]. DNA was purified using
the Maxiprep Kit (Qiagen) and injected at a concentration of
15 ng/ml.
A Leica fluorescent microscope (Leica MZFLIII) was used to
examine GFP expression in live embryos. Injected embryos were
analyzed at different stages to determine the spatio-temporal
pattern of GFP expression. As the hsp70 core promoter is
activated by temperature changes, the embryos were kept and
examined at constant room temperature. Developmental stages
were determined by morphological features as described by
Iwamatsu [50].
Whole mount in-situ hybridization
For analysis of scamp1, fign(1 of 2), atg4c, gon3_oryla and kcnh7
expression patterns, fragments were PCR amplified from medaka
cDNA (using Taq-Polymerase, primer sequences in Table S8)
and subcloned using the TOPO TA Cloning Kit (Invitrogen).
After verification by sequencing, Digoxigenin incorporated
antisense-RNA probes were generated by in-vitro transcription
with Sp6 or T7 RNA Polymerase (NEB).
Probe preparation and whole mount in-situ hybridization were
performed as described previously [51]. For the remaining genes
analyzed, we could find at least one clone matching part of the
transcript sequence in our in-house library (in pCMV-Sport6.1).
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Medaka annotation
The medaka nervous system ontology is derived from
the medaka fish anatomy and development OBO ontology
(medaka_ontology.obo). The descendent terms of nervous system
at various stages were extracted. A total of 32 different terms were
found and used for the controlled vocabulary annotation.
Reporter gene expression was found in 20 (62%) of these
anatomical terms.
Supporting Information
Figure S1 A. Location of the predicted CRMs relative to
genes in the medaka genome. The percentage of intragenic,
intergenic (,100 kb) and intergenic (.100 kb) locations for all
the 23,011 predicted CRMs (left), the 491 vertebrate conserved
CRMs (center) and 23,011 random positions in the genome
(right) is calculated. The distribution of the CRMs in each
category is significantly different compared to random locations,
with more CRMs being intergenic (.100 kb). B. Locations of
the predicted CRMs relative to the nearest annotated TSS in
the medaka genome. For all the 23,011 predicted CRMs (left),
the 491 vertebrate conserved CRMs (center) and 23,011
random positions in the genome (right) the distance to the
nearest TSS is calculated and binned into less than 1, 1–10, 10–
100 and more than 100 kb windows. The percentage of regions
for each bin is then calculated. The distribution of the CRMs
in each bin is significantly different compared to random
locations, with more CRMs being closer to the nearest TSS than
expected.
(TXT)
Figure S2 Enhanceractivityofthe additional10predictedCRMs
evenly distributed among the 200 top scoring candidates. Example
of injected fish showing a reproducible expression pattern. (a)
MEDMOD021445 (b) MEDMOD092210 (c) MEDMOD062490
(d) MEDMOD057815 (e) MEDMOD021442 (f) MED-
MOD093196 (g) MEDMOD062408 (h) MEDMOD047799 (i)
MEDMOD083481 (j) MEDMOD062206.
(TXT)
Figure S3 Stable lines at various developmental stages and views
for MEDMOD021953. Stage 26–30: Telencephalon, retina
ganglion cells (RGCs), tectum central zone, cerebellum, hypothal-
amus, rombomeres, alar plate. Stage 33–35: Telencephalon,
tectum central zone, hypothalamus, cerebellum, hindbrain,
RGCs, tegmentum.
(TXT)
Figure S4 Stable lines at various developmental stages and views
for MEDMOD062451. Stage 27: One group of cells in the
hypothalamus (bilateral) or tegmentum. Stage 32: Optic tectum
differentiated cells (central zone), torsus semicircularis, few cells in
cerebellum, lateral part of the myelencephalon, hindbrain: two
lateral rows cells and two medial rows of cells (motor neurons).
Stage 35: Telencephalon posterior (area ventro-posterior), optic
tectum: differentiated cells (peri-ventricular grey zone, deap layer),
torsus semicircularis, midbrain dorsal, a few cells in the cerebellum
anlage, hindbrain: Two lateral rows cells and two medial rows of
cells (motoneurons).
(TXT)
Figure S5 Stable lines at various developmental stages
and views for MEDMOD074008 and MEDMOD021885.
MEDMOD074008 stages 28–37: Tectum central zone and
olfactory pits. MEDMOD021885 stages 34–35: Diencephalon.
Two groups of neurons with contralateral projections.
(TXT)
Figure S6 Stable lines at various developmental stages and views
for MEDMOD070042. Stage 32–34: Diencephalum pretectal
nuclei, four rows of cells, two median two lateral row of cells.
Medials are motoneurons, the lateral ones are sensory or
interneurons.
(TXT)
Figure S7 Stable lines at various developmental stages and
views for MEDMOD046007 and MEDMOD045693. MED-
MOD046007 stage 32–34: Optic tectum (anterior and central
zone), diencephalon and hypothalamus. MEDMOD045693 stage
24–32: Hypothalamus and maybe pectoral fins.
(TXT)
Figure S8 Stable lines at various developmental stages and views
for MEDMOD086628. Stage 28–34: Rhombomeres.
(TXT)
Figure S9 Stable lines at various developmental stages and
views for MEDMOD062537. Stage 22: Dorsal part of the
retina and hypothalamus. Stage 25–32: Retina, forebrain and
hypothalamus.
(TXT)
Table S1 List of all predicted CRMs. Medaka coordinates
(genome version MEDAKA1) of all the predicted CRMs.
(PDF)
Table S2 List of predicted vertebrate conserved CRMs. Medaka
coordinates (genome version MEDAKA1) of all the predicted
vertebrate conserved CRMs.
(PDF)
Table S3 List of conserved and non-conserved CRMs for each
tissue. Tab delimited list of tissues from ZFIN (column 1) with the
corresponding medaka genes (column 2) and the corresponding
CRM ids (column 3). The conservation of the CRMs is reported in
column 4. For details, see the material and methods section.
(PDF)
Table S4 Enrichment of vertebrate conserved CRMs around
genes expressed in neuronal tissues. For each selected develop-
mental tissue (first column) and stage, the percentage of genes
expressed in the given tissue that are linked to at least one
vertebrate conserved CRMs (third column) or to at least one
predicted CRMs (fourth column) is calculated. The statistical
significance is calculated with a one-sided fisher test (second
column). For details see methods section and Supplementary
Table 3.
(PDF)
Table S5 Injection success rate. ‘‘Alive’’ column corresponds
to the number of injected embryos which passed gastrulation.
‘‘Expression’’ corresponds to the number of embryos with
expression pattern in the lens (successful injection) and ‘‘Specific
Expression’’ corresponds to the number of embryos with
reproducible expression pattern excluding the lens specific pattern.
(PDF)
Table S6 Genomic location, length (in bp), scores and enhancer
activity of the tested CRMs. (a) For the 10 top scoring candidates.
(b) For the 10 candidates evenly distributed amongst the 200 top
scoring candidates.
(PDF)
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CRMs. MEDMOD062537, MEDMOD045693 and MED-
MOD086628. For each transcription factor, the name of the
factor (from transfac or Jaspar), the name of the zebrafish
homolog, the PWM and the partial expression pattern (from
ZFIN) is recorded.
(PDF)
Table S8 Primer list. Description of all the primers used in this
study (candidate CRMs cloning, in-situ probe generation).
(PDF)
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